Brought to you by 
Series A for ProtAffin brings in €2.65mm; adds €1.35mm
14 Jan 2008
Executive Summary
Inflammation start-up ProtAffin Biotechnologie AG brought in €2.65mm ($3.6mm) through its Series A financing led by Aescap Venture Management with additional participation from Z-Cube SRL. Both investors contribute a new member to the company's board.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A for ProtAffin brings in €2.65mm; adds €1.35mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice